Monitoring of Hepatitis B Virus (HBV) DNA and Risk of HBV Reactivation in B-Cell Lymphoma: A Prospective Observational Study | Zendy

Shigeru Kusumoto | Zendy; Yasuhito Tanaka | Zendy; Ritsuro Suzuki | Zendy; Takashi Watanabe | Zendy; Masanobu Nakata | Zendy; Hirotaka Takasaki | Zendy; Noriyasu Fukushima | Zendy; Takuya Fukushima | Zendy; Yukiyoshi Moriuchi | Zendy; Kuniaki Itoh | Zendy; Kisato Nosaka | Zendy; Ilseung Choi | Zendy; Masashi Sawa | Zendy; Rumiko Okamoto | Zendy; Hideki Tsujimura | Zendy; Toshiki Uchida | Zendy; Sachiko Suzuki | Zendy; Masataka Okamoto | Zendy; Tsutomu Takahashi | Zendy; Isamu Sugiura | Zendy; Yasushi Onishi | Zendy; Mika Kohri | Zendy; Shinichiro Yoshida | Zendy; Rika Sakai | Zendy; Minoru Kojima | Zendy; Hiroyuki Takahashi | Zendy; Akihiro Tomita | Zendy; Dai Maruyama | Zendy; Yoshiko Atsuta | Zendy; Eiji Tanaka | Zendy; Takayo Suzuki | Zendy; Tomohiro Kinoshita | Zendy; Michinori Ogura | Zendy; Masashi Mizokami | Zendy; Ryuzo Ueda | Zendy

Open Access

Monitoring of Hepatitis B Virus (HBV) DNA and Risk of HBV Reactivation in B-Cell Lymphoma: A Prospective Observational Study

Author(s) -

Shigeru Kusumoto,

Yasuhito Tanaka,

Ritsuro Suzuki,

Takashi Watanabe,

Masanobu Nakata,

Hirotaka Takasaki,

Noriyasu Fukushima,

Takuya Fukushima,

Yukiyoshi Moriuchi,

Kuniaki Itoh,

Kisato Nosaka,

Ilseung Choi,

Masashi Sawa,

Rumiko Okamoto,

Hideki Tsujimura,

Toshiki Uchida,

Sachiko Suzuki,

Masataka Okamoto,

Tsutomu Takahashi,

Isamu Sugiura,

Yasushi Onishi,

Mika Kohri,

Shinichiro Yoshida,

Rika Sakai,

Minoru Kojima,

Hiroyuki Takahashi,

Akihiro Tomita,

Dai Maruyama,

Yoshiko Atsuta,

Eiji Tanaka,

Takayo Suzuki,

Tomohiro Kinoshita,

Michinori Ogura,

Masashi Mizokami,

Ryuzo Ueda

Publication year - 2015

Publication title -

clinical infectious diseases

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 3.44

H-Index - 336

eISSN - 1537-6591

pISSN - 1058-4838

DOI - 10.1093/cid/civ344

Subject(s) - medicine , hepatitis b virus , hbsag , virology , hepatitis b , immunology , antibody , gastroenterology , virus

There is no standard management of reactivation of hepatitis B virus (HBV) infection in HBV-resolved patients without hepatitis B surface antigen (HBsAg), but with antibodies against hepatitis B core antigen and/or antibodies against HBsAg (anti-HBs).

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research